Biocad

This study is testing a new drug called BCD-261 for adults with moderate to severe Crohn's disease who haven't gotten enough relief from standard treatments. Researchers will compare different doses of the drug against a placebo to see if it helps reduce gut inflammation and symp…

This study is testing a new drug called BCD-261 for adults with moderate to severe ulcerative colitis who haven't gotten enough relief from standard treatments. About 198 participants will receive either the new drug at different doses or a placebo to see which works better at ca…

This study is testing whether a new drug called BCD-281 works as well as an existing reference drug for people with relapsing-remitting multiple sclerosis (RRMS). About 292 participants will be randomly assigned to receive either BCD-281 or the reference drug for 72 weeks, follow…

This study is testing whether a single dose of an experimental gene therapy called ANB-002 can control bleeding as well as, or better than, the standard preventive injections of clotting factor (FIX) in adults with severe hemophilia B. Participants will first be monitored for 6 m…

This study aims to see how a new drug called BCD-057 compares to the existing drug Humira. It will involve 444 healthy men who will receive a single injection of either BCD-057 or Humira. Researchers will track how the body processes the drugs and check for any side effects or im…